Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
AlertEU Panel Backs Dolutegravir/Rilpivirine Combo Pill for HIVThe once-daily pill can maintain viral suppression in patients on a stable antiretroviral regimen with no known or suspected resistance to a non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.
Improving Outcomes Will Take More Than Clinical CareAfter Katrina, the New Orleans healthcare system had to be rebuilt. Partnerships with governments, churches, and social services
led to the creation of an inventive, more resilient system.
Personalized Letter Aids Those With Gestational DiabetesWomen with gestational diabetes who received a customized letter upon diagnosis listing recommendations regarding expected
weight gain were significantly more likely to meet national guidelines, a study finds.
Are Pharmacists Your Competitors or Your Collaborators?As physicians struggle to keep up with demand for their services, pharmacists are picking up some of that business. Many physicians are comfortable with this, but others feel differently.
Should Clinicians With Conscientious Objections Be Protected?HHS' Conscience and Religious Freedom Division is intended to protect healthcare professionals who want to opt out of performing certain procedures or providing certain medications. Is this necessary?
Medscape Business of Medicine, March 30, 2018
The Future of Medicine From a Leader in BiosensorsDr Eric Topol talks with pioneering researcher John Rogers about how his flexible electronic devices are being used in medicine and what further developments lie ahead.
Eric J. Topol, MDDirector, Scripps Translational Science Institute; Executive Vice President and Professor of Molecular Medicine, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape
